Literature DB >> 22210467

Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.

M M AlHilli1, S C Dowdy, A L Weaver, J L St Sauver, G L Keeney, A Mariani, K C Podratz, J N Bakkum-Gamez.   

Abstract

OBJECTIVE: To estimate the incidence of synchronous endometrial cancer (EC) and ovarian cancer (OC) in the female population, among all women with EC, and in women under 50 years of age with EC, and to identify factors associated with synchronous EC/OC.
METHODS: All cases of synchronous EC/OC and EC diagnosed in women residing in Olmsted County, Minnesota between 1/1/1945 and 12/31/2008 were identified. Incidence was estimated using the population denominator from decennial census data, corrected for hysterectomy prevalence. A case-control study using 15 identified cases (EC/OC) and 45 controls (EC alone) was performed.
RESULTS: The incidence of synchronous EC/OC and EC (age-adjusted to the 2000 US female total and corrected for hysterectomy prevalence) in 1945-2008 was 0.88 and 30.3 per 100,000 person-years, respectively. Among women under 50 years of age, the corrected incidence of EC/OC and EC was 0.51 and 5.1 per 100,000 person-years, respectively. Among all women with EC, 3.1% had a synchronous OC compared to 9.4% of women under 50 years of age with EC. Patients with synchronous EC/OC were more likely than those with EC alone to present with a pelvic mass (57.1% vs. 8.9%, p<0.001). Patients with EC alone were more likely to have used oral contraceptive pills (OCPs) than synchronous EC/OC cases (22.7% vs 0%; Odds ratio, 0.10; 95% CI, <0.01-0.87).
CONCLUSION: Although the incidence of synchronous EC/OC in the general population is lower than previously reported, nearly 1 in 10 women diagnosed with EC under 50 years of age will have a synchronous OC. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210467      PMCID: PMC3495058          DOI: 10.1016/j.ygyno.2011.12.444

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  34 in total

1.  Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment?

Authors:  Isabelle Navarria; Massimo Usel; Elisabetta Rapiti; Isabelle Neyroud-Caspar; Marie-Françoise Pelte; Christine Bouchardy; Patrick Petignat
Journal:  Gynecol Oncol       Date:  2009-06-27       Impact factor: 5.482

2.  Factors associated with Type I and Type II endometrial cancer.

Authors:  Ashley S Felix; Joel L Weissfeld; Roslyn A Stone; Robert Bowser; Mamatha Chivukula; Robert P Edwards; Faina Linkov
Journal:  Cancer Causes Control       Date:  2010-07-14       Impact factor: 2.506

3.  Endometrial cancer in Olmsted County, MN: trends in incidence, risk factors and survival.

Authors:  C M Beard; L C Hartmann; G L Keeney; C S Crowson; G D Malkasian; P C O'Brien; L J Melton
Journal:  Ann Epidemiol       Date:  2000-02       Impact factor: 3.797

4.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

5.  Characteristics and outcome of endometrial carcinoma patients age 45 years and younger.

Authors:  B N Tran; P P Connell; S Waggoner; J Rotmensch; A J Mundt
Journal:  Am J Clin Oncol       Date:  2000-10       Impact factor: 2.339

Review 6.  The effect of aging on fertility.

Authors:  L Speroff
Journal:  Curr Opin Obstet Gynecol       Date:  1994-04       Impact factor: 1.927

Review 7.  Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship.

Authors:  Amanda Nickles Fader; Lucybeth Nieves Arriba; Heidi E Frasure; Vivian E von Gruenigen
Journal:  Gynecol Oncol       Date:  2009-04-29       Impact factor: 5.482

8.  Synchronous carcinomas of the uterine corpus and ovary.

Authors:  R J Zaino; E R Unger; C Whitney
Journal:  Gynecol Oncol       Date:  1984-11       Impact factor: 5.482

9.  Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.

Authors:  L A Brinton; R N Hoover
Journal:  Obstet Gynecol       Date:  1993-02       Impact factor: 7.661

10.  Histologic transformation of benign endometriosis to early epithelial ovarian cancer.

Authors:  R Sainz de la Cuesta; J H Eichhorn; L W Rice; A F Fuller; N Nikrui; B A Goff
Journal:  Gynecol Oncol       Date:  1996-02       Impact factor: 5.482

View more
  8 in total

1.  Developing a validated nomogram for predicting ovarian metastasis in endometrial cancer patients: a retrospective research.

Authors:  Peishu Liu; Xiaolei Zhang; Xiaodie Liu; Yaohai Wu
Journal:  Arch Gynecol Obstet       Date:  2021-09-08       Impact factor: 2.344

2.  Synchronous granulosa cell tumor of the ovary and endometrial adenocarcinoma.

Authors:  Sarah M Abuali; Armand Asarian; Philip Xiao
Journal:  J Surg Case Rep       Date:  2022-04-23

3.  Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.

Authors:  Yuxuan Wang; Lu Li; Christopher Douville; Joshua D Cohen; Ting-Tai Yen; Isaac Kinde; Karin Sundfelt; Susanne K Kjær; Ralph H Hruban; Ie-Ming Shih; Tian-Li Wang; Robert J Kurman; Simeon Springer; Janine Ptak; Maria Popoli; Joy Schaefer; Natalie Silliman; Lisa Dobbyn; Edward J Tanner; Ana Angarita; Maria Lycke; Kirsten Jochumsen; Bahman Afsari; Ludmila Danilova; Douglas A Levine; Kris Jardon; Xing Zeng; Jocelyne Arseneau; Lili Fu; Luis A Diaz; Rachel Karchin; Cristian Tomasetti; Kenneth W Kinzler; Bert Vogelstein; Amanda N Fader; Lucy Gilbert; Nickolas Papadopoulos
Journal:  Sci Transl Med       Date:  2018-03-21       Impact factor: 17.956

4.  Synchronous Endometrial and Ovarian Carcinoma: A Case Series.

Authors:  Georgios-Marios Makris; Georgia Manousopoulou; Marco-Johannes Battista; Ioannis Salloum; Georgios Chrelias; Charalampos Chrelias
Journal:  Case Rep Oncol       Date:  2017-08-09

5.  Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.

Authors:  Casper Reijnen; Heidi V N Küsters-Vandevelde; Marjolijn J L Ligtenberg; Johan Bulten; Marloes Oosterwegel; Marc P L M Snijders; Sanne Sweegers; Joanne A de Hullu; Maria C Vos; Anneke A M van der Wurff; Anne M van Altena; Astrid Eijkelenboom; Johanna M A Pijnenborg
Journal:  Int J Cancer       Date:  2020-02-18       Impact factor: 7.396

6.  Trends and outcomes of women with synchronous endometrial and ovarian cancer.

Authors:  Koji Matsuo; Hiroko Machida; Erin A Blake; Laura L Holman; Bobbie J Rimel; Lynda D Roman; Jason D Wright
Journal:  Oncotarget       Date:  2018-06-19

7.  The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.

Authors:  Xiangbo Zhan; Lei Li; Ming Wu; Jinghe Lang
Journal:  Arch Gynecol Obstet       Date:  2019-09-14       Impact factor: 2.344

8.  How to manage synchronous endometrial and ovarian cancer patients?

Authors:  Wonkyo Shin; Sang-Yoon Park; Sokbom Kang; Myong Cheol Lim; Sang-Soo Seo
Journal:  BMC Cancer       Date:  2021-05-01       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.